Mycoplasmas are cell wall-less bacteria considered among the smallest and simplest prokaryotes known, and yet several species including Mycoplasma pneumoniae have a remarkably complex cellular organization highlighted by the presence of a differentiated terminal organelle, a membrane-bound cell extension distinguished by an electron-dense core. Adhesin proteins localize specifically to the terminal organelle, which is also the leading end in gliding motility. Duplication of the terminal organelle is thought to precede cell division, but neither the mechanism of its duplication nor its role in this process is understood. Here we used fluorescent protein fusions and time-lapse digital imaging to study terminal organelle formation in detail in growing cultures of M. pneumoniae. Individual cells ceased gliding as a new terminal organelle formed adjacent to an existing structure, which then migrated away from the transiently stationary nascent structure. Multiple terminal organelles often formed before cytokinesis was observed. The separation of terminal organelles was impaired in a nonmotile mutant, indicating a requirement for gliding in normal cell division. Examination of cells expressing two different fluorescent protein fusions concurrently established their relative order of appearance, and changes in the fluorescence pattern over time suggested that nascent terminal organelles originated de novo rather than from an existing structure. In summary, spatial and temporal analysis of terminal organelle formation has yielded insights into the nature of M. pneumoniae cell division and the role of gliding motility in that process.cell division ͉ gliding motility ͉ adherence ͉ fluorescent protein fusion M ycoplasma pneumoniae causes chronic infections of the human respiratory tract, including bronchitis and primary atypical or ''walking'' pneumonia, accounting for up to 30% of all community-acquired pneumonia, particularly among older children and young adults. M. pneumoniae infections can result in chronic or permanent lung damage, and a growing body of evidence supports a correlation with the onset, exacerbation, and recurrence of asthma. Furthermore, extrapulmonary sequelae are not uncommon, reflecting both invasive and immunopathological components to M. pneumoniae disease (1).In addition to its significant impact on public health, M. pneumoniae is intriguing from a biological perspective. Mycoplasmas have no cell wall and are among the smallest known cells, with M. pneumoniae having a cell volume only Ϸ5% of that of Escherichia coli. Likewise, at 816 kb the M. pneumoniae genome is among the smallest known for a cell capable of a free-living existence, lacking genes for cell wall production, de novo synthesis of nucleotides and amino acids, and twocomponent or other common bacterial transcriptional regulators (2, 3). Nevertheless, a remarkable level of structural complexity underlies what are otherwise considered minimal cells (4). Thus, experimental evidence indicated the presence of cytoskeletal structure and fu...